Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 805,346 ordinary shares
- Purchase Date: May 23, 2025
- Highest Price Paid: 415.10 pence per share
- Lowest Price Paid: 409.10 pence per share
- Volume Weighted Average Price: 411.79 pence per share
- Post-Transaction Share Capital: 9,008,531,807 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,004,451,602
Material Changes
The primary material change reported is the reduction of the company's share count through the cancellation of 805,346 shares purchased on May 23, 2025. This transaction updates the total number of ordinary shares with voting rights to 9,004,451,602.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of voting shares (9,004,451,602) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Confirm the execution of the buyback programme initiated on March 28, 2025.
- Review the individual trade breakdown available via the provided London Stock Exchange link for granular transaction data.